Terug
Dagbereik
€ 5,51
€ 5,51
52-Weeksbereik
€ 5,00
€ 6,70
Volume
100
50D / 200D Gem.
€ 5,23
/
€ 5,92
Vorige Slotkoers
€ 5,51
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 104,5 | 0,4 |
| P/B | 6,9 | 2,9 |
| ROE % | 6,7 | 3,8 |
| Net Margin % | 6,2 | 3,9 |
| Rev Growth 5Y % | 0,7 | 10,0 |
| D/E | 0,5 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2026 |
€ 0,00
€ 0,00 – € 0,00
|
230 M | 0 |
Belangrijkste Punten
Revenue grew 0,74% annually over 5 years — modest growth
Earnings grew 22,61% over the past year
Generating 30,52M in free cash flow
P/E of 104,52 — premium valuation
Cash machine — converts 190,52% of earnings into free cash flow
Capital efficient — spends only 7,06% of revenue on capex
Groei
Revenue Growth (5Y)
0,74%
Revenue (1Y)-1,64%
Earnings (1Y)22,61%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
6,73%
ROIC5,67%
Net Margin6,22%
Op. Margin10,94%
Veiligheid
Debt / Equity
0,54
Current Ratio2,47
Interest Coverage4,78
Waardering
P/E Ratio
104,52
P/B Ratio6,90
EV/EBITDA62,37
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,64% | Revenue Growth (3Y) | -3,14% |
| Earnings Growth (1Y) | 22,61% | Earnings Growth (3Y) | -25,96% |
| Revenue Growth (5Y) | 0,74% | Earnings Growth (5Y) | -10,68% |
| Profitability | |||
| Revenue (TTM) | 257,62M | Net Income (TTM) | 16,02M |
| ROE | 6,73% | ROA | 3,60% |
| Gross Margin | 29,65% | Operating Margin | 10,94% |
| Net Margin | 6,22% | Free Cash Flow (TTM) | 30,52M |
| ROIC | 5,67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,54 | Current Ratio | 2,47 |
| Interest Coverage | 4,78 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 104,52 | P/B Ratio | 6,90 |
| P/S Ratio | 6,50 | PEG Ratio | -1,62 |
| EV/EBITDA | 62,37 | Dividend Yield | 0,00% |
| Market Cap | 1,67B | Enterprise Value | 1,76B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 257,62M | 261,91M | 274,63M | 287,34M | 250,10M |
| Net Income | 16,02M | 13,07M | 29,22M | 39,96M | 25,18M |
| EPS (Diluted) | 0,05 | 0,21 | 0,48 | 0,66 | 0,47 |
| Gross Profit | 76,39M | 64,85M | 79,49M | 87,71M | 68,99M |
| Operating Income | 28,18M | 25,44M | 40,01M | 48,18M | 32,48M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 445,06M | 466,58M | 397,50M | 368,53M | 331,90M |
| Total Liabilities | 202,53M | 233,25M | 172,32M | 162,77M | 159,36M |
| Shareholders' Equity | 242,53M | 233,33M | 225,18M | 205,76M | 172,55M |
| Total Debt | 130,53M | 141,37M | 87,15M | 85,30M | 109,58M |
| Cash & Equivalents | 47,16M | 33,53M | 22,67M | 47,18M | 37,56M |
| Current Assets | 223,50M | 247,98M | 211,39M | 188,02M | 156,28M |
| Current Liabilities | 90,35M | 96,43M | 60,25M | 45,67M | 35,67M |